Bio-Techne Corporation
TECH
$62.53
-$1.29-2.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 286.56M | 316.96M | 316.18M | 297.03M | 289.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 286.56M | 316.96M | 316.18M | 297.03M | 289.46M |
| Cost of Revenue | 96.36M | 105.81M | 101.08M | 100.27M | 101.36M |
| Gross Profit | 190.19M | 211.15M | 215.10M | 196.76M | 188.10M |
| SG&A Expenses | 124.37M | 66.64M | 149.37M | 118.99M | 113.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 244.98M | 201.92M | 271.60M | 244.27M | 239.01M |
| Operating Income | 41.58M | 115.05M | 44.58M | 52.76M | 50.44M |
| Income Before Tax | 47.99M | -22.86M | 38.27M | 42.88M | 40.17M |
| Income Tax Expenses | 9.81M | -5.18M | 15.69M | 7.99M | 6.57M |
| Earnings from Continuing Operations | 38.19M | -17.68M | 22.59M | 34.89M | 33.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.19M | -17.68M | 22.59M | 34.89M | 33.60M |
| EBIT | 41.58M | 115.05M | 44.58M | 52.76M | 50.44M |
| EBITDA | 65.92M | 142.16M | 72.15M | 79.84M | 78.58M |
| EPS Basic | 0.25 | -0.11 | 0.14 | 0.22 | 0.21 |
| Normalized Basic EPS | 0.17 | 0.47 | 0.18 | 0.19 | 0.20 |
| EPS Diluted | 0.24 | -0.12 | 0.14 | 0.22 | 0.21 |
| Normalized Diluted EPS | 0.17 | 0.47 | 0.17 | 0.19 | 0.20 |
| Average Basic Shares Outstanding | 155.46M | 154.91M | 157.37M | 158.43M | 158.53M |
| Average Diluted Shares Outstanding | 156.36M | 155.76M | 158.94M | 160.63M | 161.12M |
| Dividend Per Share | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 32.59% | -70.07% | 55.69% | 36.50% | 37.76% |